Concepedia

Publication | Open Access

Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma

DOIFull Paper Access

29

Citations

25

References

2025

Year

Michael Wang, David Šálek, David Belada, Yuqin Song, Wojciech Jurczak, Brad S. Kahl, Jonas Paludo, Michael P. Chu, Iryna Kryachok, Laura Maria Fogliatto,
Journal of Clinical Oncology

Abstract

The combination of acalabrutinib with bendamustine-rituximab significantly improved PFS. Clinical benefit of acalabrutinib with bendamustine-rituximab was achieved with manageable toxicity.

References

YearCitations

Page 1